Market News: OpenAI introduces AI model for Pharmaceutical Research
OpenAI introduced GPT-Rosalind, an AI model designed to support pharmaceutical development and research. The model aims to strengthen early-phase research and potentially help reduce the traditional 10–15 year U.S. drug approval timeline. Read more about pharmacy market news in our Weekly Dose newsletter!
Amneal Launches Beclomethasone MDI
April 2026 — Amneal Pharmaceuticals, Inc. (“Amneal” or the “Company”) (Nasdaq: AMRX) announced the U.S. launch of beclomethasone dipropionate HFA inhalation aerosol…
Report: Pharmacy500 Branding Analysis
The Pharmacy500 are the pharmacy operations supply chain businesses and associations that significantly impacted dispensing pharmacies over the past year. This report analyzes the Pharmacy500 logos and their visual elements to provide insight into branding trends.
Report: Cardinal Health Teardown
RXinsider’s company teardown reports provide educational insights into company structure, emerging trends, investments, strategic initiatives, product overviews, and more. Learn more about Cardinal Health in this report.
INTEL Insights: Manufacturing
Discover insights into manufacturing and the Pharmacy 500 companies that shape the industry in the Pharmacy500 Platinum Pages 2026 publication!
Report: 2026 Pharmacy500 Companies Market Teardown
The 2026 Pharmacy500 Companies Market Teardown report provides a concise snapshot of the 2026 companies, highlighting new additions, examining regional distributions, practice settings, supply chain categories, and key conferences attended.
Report: Pharmacy500 Career Outlook Report
RXinsider’s Pharmacy500 Careers Outlook report identifies key employment trends and workforce dynamics across Pharmacy500 companies. Check out this report to learn more about open position trends and the current state of the job market impacting the pharmacy supply chain!
Report: Pharmacy’s Impact on the Fortune500
Fortune Magazine’s annual Fortune 500 ranks the largest U.S. companies by revenue. Many leaders in healthcare and pharmaceuticals drive medication production, distribution, and patient access. This report highlights their impact on the pharmacy industry.
YARAL Pharma
YARAL Pharma Inc., launched in 2022, is the U.S. generics subsidiary of IBSA (Institut Biochimique SA), a multinational pharmaceutical company headquartered in Lugano, Switzerland. Built on IBSA’s commitment to “drugs in the best form,” YARAL delivers high-quality, affordable, authorized and complex generic medicines across key therapeutic areas—including endocrinology and pain and inflammation—while ensuring continuity of supply […]
Profile: YARAL Pharma Inc.
YARAL Pharma delivers high-quality, authorized, and complex generics across multiple therapeutic areas, with reliable supply and exceptional service. Learn more by exploring our 20Ways publications!
